Ibrutinib

Description

Imbruvica (ibrutinib) is an oral prescription medication that acts as a kinase inhibitor to help treat certain blood cancers. Available as tablets (140mg, 230mg, 420mg, 560mg), capsules (70mg, 140mg), and suspension (70mg/mL), it's manufactured by Pharmacyclics LLC. This information was generated using AI and is provided for informational and research purposes only.

Resources

Name Format Description Link
21 Access the FDA dataset for Ibrutinib — ANDA 205552 submitted by Mylan Institutional LLC https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205552

Tags

  • fda
  • drug-safety
  • health-care
  • prescription-drugs
  • pharmaceuticals

Topics

Categories